Table 1 Baseline demographics for the 50 trial patients
Age, years | 59 ± 13 |
Male | 90% |
Indication, n (%) | |
Bridge to transplantation | 27 (54%) |
Destination therapy | 23 (46%) |
INTERMACS profile | |
Profile 2 | 5 (10%) |
Profile 3 | 21 (42%) |
Profile 4 | 20 (40%) |
Profile 5 | 3 (6%) |
Profile 6 | 1 (2%) |
Inotropes | 29 (58%) |
Previous sternotomy | 10 (20%) |